4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-041982
Chief Scientific Officer sold 3,000 shares at an average $83.50 ($250,503)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-07-05 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-07-05 | Sale | −2,700 | $83.41 | $225,207 | 57,496 | D |
| Biller Scott Chief Scientific Officer | 2018-07-05 | Sale | −300 | $84.32 | $25,296 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-07-05 | Option exercise · Stock options (right to buy) | +3,000 | 16,154 | D | ||
| Open-market sales · 3,000 sh · avg $83.50 · $250,503 | |||||||
Loading xslF345X03/doc4.xml…